What is Exponent's gross profit margin?

What is the revenue and EPS growth rate for Exponent year over year?

What does Exponent do and what are its main business segments?

What were the key takeaways from Exponent’s earnings call?

Did Exponent beat or miss consensus estimates last quarter?

What guidance did Exponent's management provide for the next earnings period?

What is Exponent's latest dividend and current dividend yield?

What is the market's earnings forecast for Exponent next quarter?

- **Revenue Growth**: 10% net revenue increase to $137.1 million, driven by 18% growth in reactive engagements.
- **AI Expansion**: Balancing reactive litigation and proactive algorithm validation, with rapid industry adoption.
- **Financial Strength**: $28 million net income, 28.3% EBITDA margin, and $40 million in Q3 stock buybacks.
- **2026 Outlook**: 4-6% FTE growth, targeting 3-3.5% rate realization as hiring resumes.

**【CEO Summary Section】**
- Exponent reported 8% total revenue growth to $147.1 million, with net revenue up 10% to $137.1 million, driven by double-digit growth in reactive engagements across energy, transportation, and life sciences sectors.
- Proactive engagements in risk management (utility sector) and regulatory consulting (chemicals) offset lower activity in consumer electronics, with improving demand trends expected in Q4.
- AI integration is accelerating across industries, with Exponent leveraging its expertise in failure analysis and human-machine interaction to address safety-critical AI challenges.
- The company is investing in talent to maintain its technical leadership, targeting 4-6% FTE growth in 2026.

**【CFO Financial Commentary】**
- Net income rose 7.7% to $28 million ($0.55 EPS), with EBITDA up 9% to $38.8 million (28.3% margin).
- Billable hours increased 4% to 376,000, with utilization at 74.1% and a 6% realized rate increase.
- Q4 2025 guidance: net revenue growth in low to mid-single digits, EBITDA margin 26-27%, and full-year EBITDA margin 27.4-27.65%.
- $40 million in Q3 stock buybacks and a $100 million increase to the repurchase program reflect confidence in long-term growth.

**【Q&A Highlights】**
- **Hiring Strategy**: 2026 FTE growth expected in 4-6% range, focused on AI, digital health, and energy transition.
- **AI Impact**: Balanced across reactive (litigation, medical devices) and proactive (algorithm validation, hardware design) work, with rapid adoption across industries.
- **Segment Growth**: Reactive engagements grew 18%, while proactive was flat (regulatory consulting gains offset consumer electronics decline).
- **Government Shutdown Impact**: Minimal (2-3% of revenue), with ongoing contracts unaffected.
- **Rate Realization**: 6% in Q3, expected to normalize to 3-3.5% as entry-level hires dilute senior rate mix.

Exponent, Inc. (EXPO) Q3 2025 Earnings Call Transcript

- **Revenue resilience**: Q2 2025 net revenue flat but beat expectations, driven by dispute-related work (+7% YoY in litigation) and utility risk management.
- **Headcount recovery**: FTE deficit narrowed to 2% YoY, with Q3/Q4 headcount growth expected after 5-6% deficit at start of year.
- **Profit margin pressure**: EBITDA margin 27.8% (-240bps YoY) due to lower utilization (72.1% vs. 75.1%) and higher operating expenses.
- **Future growth areas**: AI in medical devices, energy transition technologies, and advanced driver assistance systems.
- **2026 optimism**: CEO highlights wearables/sensors, energy infrastructure, and AI as key growth drivers, with CFO targeting 4-8% FTE growth.

**【CEO Summary Section】**
- Q2 2025 revenue was flat but exceeded expectations, driven by growth in dispute-related activities (construction, automotive, medical devices) and proactive risk management work in utilities.
- Proactive engagements in utility sector (e.g., wildfire mitigation) offset softer demand in chemical regulatory work.
- Headcount improved: narrowed FTE deficit from 5-6% to 2% YoY, with Q3/Q4 headcount growth expected.
- Future growth areas include AI in safety-critical systems, energy transition (distributed energy, battery storage), and advanced driver assistance systems (ADAS).
- Competitive moat reinforced by multidisciplinary expertise and failure analysis capabilities.

**【CFO Financial Commentary】**
- Q2 2025: Total revenue $142M (+1% YoY), net revenue $132.9M (flat YoY), net income $26.6M ($0.52 EPS) vs. $29.2M ($0.57 EPS) YoY.
- EBITDA $37M (-7% YoY), margin 27.8% vs. 30.2% YoY, due to lower utilization (72.1% vs. 75.1%) and higher operating expenses.
- Billable hours down 6% YoY, FTEs 958 (-2% YoY), realized rate increase 5% YoY.
- Q3 2025 outlook: Net revenue +mid-single digits, EBITDA margin 26.75-27.75%.
- Full year 2025: Net revenue +low single digits, EBITDA margin 26.5-27%.
- Headcount expected to grow 4% YoY, utilization 72% for FY2025.

**【Q&A Key Highlights】**
- **Utilization trends**: Q2 2025 utilization decline (72.1% vs. 75.1%) due to July 4 holiday and integration of new hires.
- **Regulatory environment**: Delays in EPA/FDA approvals causing minor delays in chemical regulatory work, but medical device regulatory demand remains strong.
- **2026 outlook**: CEO cites growth drivers in wearables/sensors, energy infrastructure, ADAS, and AI in safety-critical systems.
- CFO expects 4-8% FTE growth in 2026, with rate increases returning to 2.5-3.5% range.


Exponent, Inc. (EXPO) Q2 2025 Earnings Call Transcript

- **Q1 2025 Outperformance**: Achieved flat revenue despite 5-6% FTE headwind, driven by reactive services in chemicals, transportation, and utilities.
- **Headcount Expansion**: 2% sequential growth with mid-70s utilization, reflecting selective hiring in high-demand areas.
- **Industry Diversification**: 25% of revenue from consumer electronics (2/3 proactive), 20% from energy (even split), and 90% reactive share in transportation and construction.
- **Strategic Resilience**: 60% of work is recession-resistant reactive services, balancing 40% proactive growth opportunities.

**【CEO Summary Section】**
- **Revenue Performance**: Despite a 5-6% headwind in technical full-time equivalent (FTE) employees due to resource alignment, Q1 2025 revenue remained flat year-over-year, driven by strong reactive services in chemicals, transportation, and utilities.
- **Headcount Growth**: Sequential 2% increase in headcount, supported by lower-than-expected turnover, with mid-70s utilization rates.
- **Industry Breakdown**: 
  - **Consumer Products**: 25% of revenue, 2/3 proactive (consumer electronics), 1/3 reactive.
  - **Energy**: 20% of revenue, evenly split between reactive and proactive.
  - **Transportation**: Mid-teens share, 90% reactive (dispute resolution for advanced vehicle tech).
  - **Chemicals**: Low-teens share, 60% proactive (regulatory consulting), 40% reactive.
  - **Life Sciences**: High single-digit share, evenly split between reactive and proactive.
  - **Construction**: 5-10% share, 90% reactive (complex disputes).
- **Resilience Strategy**: 60% of work is reactive (litigation, failure analysis), historically less impacted by economic cycles, with 40% proactive (risk management, R&D).

Exponent (EXPO)-1 May 25-2025 Q1 Earnings call transcript

- **Q4 2024 Highlights**: Net revenues $123.8M (+9% YoY), EBITDA margin 25.2%. Chemicals rebounded 10-15% YoY, driven by litigation.
- **2025 Outlook**: 5%-6% headwind in Q1, transitioning to low single-digit growth. Headcount to grow 1%-2% Q/Q, ending +4% YoY.
- **Key Growth Drivers**: Consumer electronics (wearables, AR/VR), utilities (grid hardening), AI in ADAS.
- **Risk Management**: 73% utilization, 28.4% EBITDA margin in FY 2024. 2025 tax rate 28% due to lease expenses and meeting costs.

**【CEO Summary Section】**
- Exponent delivered Q4 2024 revenue above expectations, with net revenues of $123.8 million (+9% YoY). Proactive services in consumer electronics and utilities drove growth, while reactive services saw robust activity in utilities and medical devices.
- Chemicals industry rebounded in Q4, with increased regulatory engagement and litigation. AI adoption in critical decision-making (e.g., ADAS) is a key growth driver.
- 2025 outlook: 5%-6% headwind from reduced headcount in Q1, transitioning to low single-digit revenue growth by year-end. Headcount expected to grow 1%-2% sequentially each quarter, ending 2025 at least 4% higher than Q1 levels.

**【CFO Financial Commentary】**
- FY 2024 net income: $109 million (+9% YoY), EBITDA: $147.1 million (28.4% margin). Q4 EBITDA: $31.2 million (25.2% margin).
- Billable hours flat YoY, utilization improved to 73% (from 69% in 2023). Average FTEs down 8% YoY, but sequential growth resumed in Q4 2024.
- 2025 guidance: EBITDA margin 26.25%-27%, tax rate 28% (vs. 26% in 2024). Stock-based compensation expected to rise to $24 million-$24.5 million.

**【Q&A Key Takeaways】**
- **Chemicals Business**: 10% of total revenue, 70% international. Q4 2024 growth in chemicals was low to mid-teens YoY, driven by litigation and regulatory work.
- **Energy Infrastructure**: 83% of net revenues, growing in proactive risk management (e.g., utility asset integrity) and reactive failure analysis (e.g., renewables projects).
- **AI Impact**: Courts apply high scrutiny to AI-generated data, maintaining Exponent's expert role in complex cases.
- **Regulatory Risk**: 3% of business directly for federal gov, unaffected by admin changes. Chemical regulatory work may shift from compliance to litigation, aligning with Exponent's strengths.

EXPO

EXPO fundamentals

Earnings Call

You can ask Aime